COVID-19: Vaccines and Therapeutics
The Food and Drug Administration today granted full approval for the Pfizer-BioNTech COVID-19 vaccine for individuals age 16 and over. The vaccine, which will now be marketed as Comirnaty, is the first COVID-19 vaccine to go beyond emergency use status in the United States.
The full approval of the Pfizer-BioNTech COVID-19 vaccine by the U.S. Food and Drug Administration (FDA) – the result of many months of work, robust data evaluation, and a thorough, comprehensive review process that has already protected more than one hundred million Americans from severe COVID-19…
The Food and Drug Administration granted full approval for the Pfizer-BioNTech COVID-19 vaccine for individuals age 16 and over.
Photo Credit: CentraCare
Phoebe Putney Health System, based in Albany, Georgia, serves more than 500,000 residents in 41 counties and has been hit hard by the pandemic. Enrique Lopez, M.D., a surgical intensivist at Phoebe Putnam Memorial Hospital who has recently helped out in Phoebe North’s COVID-19 units, gives a blunt…
Photo Credit: Wolfson Children’s Hospital
As of now, most school districts have opened or plan to reopen this month or next, so the return to in-person schooling is underway. Many kids — not to mention their parents — eagerly await the day.
In a federally funded study that enrolled more than 500 patients from U.S. hospital emergency departments, administering COVID-19 convalescent plasma to high-risk COVID-19 outpatients with early symptoms did not prevent disease progression, according to final results reported in the New England…
COVID-19 vaccine booster shots will be widely available to the American public, starting next month, according to a joint statement from Biden administration health officials.
The American Medical Association published a Current Procedural Terminology code for providers administering a potential third dose of the Moderna COVID-19 vaccine.